At a glance

  • Biotech – CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration to develop gene-edited therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia
  • Buzz off A study published in the Proceedings of the National Academy of Sciences documents the first use of CRISPER/Cas9 gene editing to target a specific gene tied to fertility in male mosquitoes.
    Chen, J. et al. (2021) Suppression of female fertility in Aedes aegypti with a CRISPR-targeted male-sterile mutation. Proceedings of the National Academy of Sciences DOI: 10.1073/pnas.2105075118
  • CRISPR-based detection of SARS-CoV-2 -Scientists have developed a CRISPR-based lab-on-paper device for detection of SARS-CoV-2.
    Yin, K. et al. (2021) Autonomous lab-on-paper for multiplexed, CRISPR-based diagnostics of SARS-CoV-2. Lab on a Chip.